Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
Journal article
Clemens SAC. et al, (2021), Nature Communications, 12
Publisher Correction: Characterisation of factors contributing to the performance of nonwoven fibrous matrices as substrates for adenovirus vectored vaccine stabilisation.
Journal article
Dulal P. et al, (2021), Sci Rep, 11
Stability of chimpanzee adenovirus vectored vaccines (Chadox1 and chadox2) in liquid and lyophilised formulations
Journal article
Berg A. et al, (2021), Vaccines, 9
Characterisation of factors contributing to the performance of nonwoven fibrous matrices as substrates for adenovirus vectored vaccine stabilisation.
Journal article
Dulal P. et al, (2021), Sci Rep, 11
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.
Journal article
Feng S. et al, (2021), Nat Med
Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs.
Journal article
Joe CCD. et al, (2021), Biotechnol Bioeng
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.
Journal article
Minassian AM. et al, (2021), Med (N Y), 2, 701 - 719.e19